Ekansh Mittal

5th Sep’20 – Hexaware Technologies Closure

Dear Members, We have released 5th Sep’20 – Hexaware Technologies Closure update. For other updates, please refer the following link – https://katalystwealth.com/category/latest-updates/ Date: 5th Sep’20   Hexaware Technologies (NSE – HEXAWARE) – Jun’20 Special Situation CMP – 406.35 (BSE); 408.95 (NSE) Rating – Neutral and Coverage Closure; this is not an investment advice (refer rating interpretation)   Hexaware Technologies is a de-listing based Special situation opportunity initiated in Jun’20 around 330-332 odd-levels. The indicative offer price for delisting is Rs 285.…

Read More

Aarti Drugs – 500% + Return in the last few months…Is it time to be Cautious?

Dear Sir, Hope you are doing well. It’s always to great to have stocks that end up multiplying your wealth several times; however, during one’s holding of such stocks there also comes a time when one needs to get cautious and have some profit protection strategy in place. Here, we are talking about Aarti Drugs. The stock has been a great wealth creator for our Premium Members as we could identify the stock at levels of 550 in Sep’18 and since…

Read More

21st Aug’20 – Jun’20 earnings update on Chaman Lal and Suven Pharma

Dear Members, We have released 21st Aug’20 – Jun’20 earnings update on Chaman Lal Setia and Suven Pharmaceuticals. The same has been produced below. For other updates, please refer the following link – https://katalystwealth.com/category/latest-updates/ Date: 21st Aug’20   Chaman Lal Setia (BSE – 530307) – Sep’19 Alpha stock CMP – 99.85 (BSE) Rating – Positive – 4% weightage; this is not an investment advice (refer rating interpretation) Source: bseindia.com Chaman Lal has reported good set of numbers for the quarter ending…

Read More

Model Portfolio – Completion of 2 Years and the Performance Card

Dear Members, Hope you all are doing well. We have completed 2 years of Model Sheet service and would like to share with you our Performance card. The Model Sheet service was started on 15th Aug’18 and the purpose of the same was 2-fold: Determine performance of our stock research on Portfolio basis (against benchmark indices) than on individual stocks basis Give an easily replicable (from any point onwards) sheet to members so that they can make the most of…

Read More